[ȸ»ç]
- ¹ÙÀÌ¿ÀÀǾàǰ ¼±µµ±â¾÷
- ¼öÆòÀûÀ̰í ÀÚÀ²ÀûÀÎ ¿Ü±¹°è ±â¾÷
[Æ÷Áö¼Ç] Á¤±ÔÁ÷
Regulatory Affairs Manager (°ú/Â÷Àå ±Þ)
[´ã´ç¾÷¹«]
- Çѱ¹ ³» ÀÓ»ó½ÃÇè °ü·Ã ±ÔÁ¦ ¾÷¹« Àü¹Ý ¸®µå (Initial CTA ½ÂÀÎ, º¯°æ½ÂÀÎ, Á¤±âº¸°í µî)
- ½Ä¾àó(MFDS) ´ë»ó ÀÓ»ó½ÃÇè Á¦Ãâ Àü·« ¼ö¸³ ¹× ´ë°ü ¾÷¹«
- ±Û·Î¹ú º»»ç ¹× À¯°ü ºÎ¼¿ÍÀÇ Çù¾÷À» ÅëÇÑ Clinical Execution ¼öÇà
- GCP Inspection ¹× Audit ´ëÀÀ, Vendor °ü¸®
[ÀÚ°Ý¿ä°Ç]
- ¾àÇÐ/»ý¸í°úÇÐ µî °ü·Ã Àü°ø Çлç ÀÌ»ó- ÃÑ °æ·Â 6~10³â (°ú/Â÷Àå±Þ)
- Çѱ¹ ½Ä¾àó CTA(ÀÓ»ó½ÃÇè°èȹ½ÂÀÎ) Á÷Á¢ ¼öÇà °æ·Â Çʼö
- ºñÁî´Ï½º ¼öÁØÀÇ ¿µ¾î Ä¿¹Â´ÏÄÉÀÌ¼Ç °¡´ÉÀÚ (Global Çù¾÷ Çʼö)
[±Ù¹«Áö]
- ¼¿ï Áß±¸
[Á¦Ãâ¼·ù]
- ±¹¿µ¹® À̷¼ ¹× ÀÚ±â¼Ò°³¼ (MS-word¸¦ 1°³ÀÇ ÆÄÀÏ·Î ÀÛ¼º)
[Á¢¼ö¹æ¹ý]
- E-mail : ******@*******.*** ±èÁöÇý Â÷Àå
ÇØ´ç ä¿ë °Ç¿¡ ´ëÇØ ±Ã±ÝÇϽŠÁ¡À̳ª ¹®ÀÇ»çÇ×ÀÌ ÀÖÀ¸½Ã¸é ¾ðÁ¦µç ÆíÇÏ°Ô ¿¬¶ôÁÖ¼¼¿ä.
====================================================
´ã´çÀÚ : ±èÁöÇý Â÷Àå / ÇìµåÇåÆÃ »ç¾÷ºÎ / AP Search
Àüȹ®ÀÇ: ***-****-****
E-mail : ******@*******.***
====================================================
[°³ÀÎÁ¤º¸°ü·Ã ¾È³»]
¿¡ÀÌÇǽáÄ¡´Â ÇìµåÇåÆÃ ¼ºñ½º Á¦°øÀ» ¸ñÀûÀ¸·Î Áö¿ø¼ ³»ÀÇ °³ÀÎÁ¤º¸¸¦ ¼öÁý, Ȱ¿ë ±×¸®°í, Áö¿øÈ¸»ç¿¡ Á¦°øÇϰí ÀÖ½À´Ï´Ù.
¿¡ÀÌÇǽáÄ¡°¡ º»ÀÎÀÇ °³ÀÎÁ¤º¸¸¦ ¼öÁý, Ȱ¿ë ±×¸®°í Áö¿ø ȸ»ç¿¡ Á¦°øÇÏ´Â °Í¿¡ µ¿ÀÇÇÏ½Ç °æ¿ì, À̷¼¸¦ Àü´ÞÇØ Áֽñ⠹ٶø´Ï´Ù.
#RA, #Regulatory Affairs, #RegulatoryAffairs, #ÀÎÇã°¡, #CTA, #ClinicalTrialApplication, #ÀÓ»óRA, #ClinicalRA, #RegulatoryManager, #½Ä¾àó´ëÀÀ, #MFDS, #¹ÙÀÌ¿ÀÅ×Å©, #Biotech, #Biotechnology, #¿Ü±¹°èÁ¦¾à»ç, #MNC, #Çõ½Å½Å¾à